Hospital
Prospect DCMH, LLC
Prospect DCMH, LLC was paid $10.37M by Medicaid between Jul 2018 and May 2024, across 135 billing codes. Its largest line is G0378, Hospital observation service, per hour — 30% of everything it billed.
33Billing provider infoPROSPECT DCMH, LLC
DREXEL HILL, PA 19026
DREXEL HILL, PA 19026
33aNPI1548624851assigned 04/12/2016
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.37M
24GClaims59,684
24DCodes billed135
24AFirst – last monthJul 2018 – May 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#29 of 154
Median peer was paid$2.82M
This provider vs. median3.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ELDERS, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 166 | $15K | |
| 2019 | 174 | $11K | |
| 2020 | 13,902 | $1.86M | |
| 2021 | 36,725 | $6.47M | |
| 2022 | 8,136 | $1.97M | |
| 2023 | 520 | $31K | |
| 2024incomplete | 61 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0378 | Hospital observation service, per hour | 30% | 1,354 | 1,241 | $3.08M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 6,331 | 6,032 | $1.91M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 4,781 | 4,574 | $1.38M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 4,839 | 4,590 | $1.26M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.4% | 1,249 | 1,219 | $357K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 2.1% | 832 | 747 | $220K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 756 | 727 | $217K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 2.0% | 1,648 | 1,553 | $208K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.7% | 927 | 921 | $172K |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 1.6% | 505 | 474 | $161K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1.4% | 231 | 226 | $148K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.3% | 562 | 549 | $138K |
123 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 1,933 | $125K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 359 | $83K |
| 59025 | Fetal non-stress test | <1% | 1,329 | $70K |
| 76830 | Ultrasound, transvaginal | <1% | 510 | $62K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 421 | $56K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 918 | $46K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 329 | $45K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 487 | $37K |
| 77066 | Tomosynthesis, mammo | <1% | 172 | $37K |
| 76801 | <1% | 382 | $31K | |
| 76642 | <1% | 314 | $31K | |
| 93017 | <1% | 224 | $28K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 136 | $27K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 219 | $26K |
| 76813 | <1% | 149 | $21K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 209 | $20K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 664 | $20K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 647 | $19K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 220 | $18K |
| 76536 | <1% | 125 | $17K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 278 | $16K |
| 93971 | <1% | 105 | $16K | |
| 72100 | <1% | 248 | $15K | |
| 76820 | <1% | 175 | $15K | |
| 71250 | <1% | 87 | $14K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 30 | $13K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 62 | $13K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 256 | $12K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 245 | $11K |
| 80053 | Comprehensive metabolic panel | <1% | 1,434 | $11K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 148 | $10K |
| 77065 | Tomosynthesis, mammo | <1% | 58 | $9K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 14 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,421 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 144 | $7K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 358 | $7K |
| 73030 | <1% | 139 | $6K | |
| 73562 | <1% | 118 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,150 | $5K |
| 73630 | <1% | 156 | $5K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 180 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 221 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,183 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 433 | $3K |
| 77080 | <1% | 25 | $3K | |
| 87631 | <1% | 49 | $3K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 555 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 386 | $3K |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 173 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 85 | $3K |
| 84484 | <1% | 877 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 779 | $2K |
| 85027 | <1% | 489 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 709 | $2K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 29 | $2K |
| 01999 | <1% | 32 | $2K | |
| 93970 | <1% | 13 | $2K | |
| 76770 | <1% | 13 | $2K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 79 | $2K |
| A0425 | Ground mileage, per statute mile | <1% | 1,064 | $1K |
| 83735 | <1% | 636 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 179 | $1K |
| 73502 | <1% | 28 | $1K | |
| 85730 | <1% | 577 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 84 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 414 | $1K |
| J3490 | Unclassified drugs | <1% | 337 | $1K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 387 | $1K |
| 97597 | <1% | 28 | $1K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 13 | $1K |
| 85610 | <1% | 620 | $1K | |
| 81001 | <1% | 910 | $1K | |
| 73610 | <1% | 44 | $1K | |
| 97162 | <1% | 14 | $910.83 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12 | $910.41 |
| 86850 | <1% | 168 | $759.50 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 226 | $750.09 |
| 73564 | <1% | 49 | $724.72 | |
| 83880 | <1% | 110 | $715.69 | |
| 0002A | <1% | 92 | $709.00 | |
| 84100 | <1% | 318 | $697.04 | |
| 86900 | <1% | 168 | $677.07 | |
| 84703 | <1% | 256 | $611.40 | |
| 83690 | <1% | 462 | $598.16 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 226 | $581.45 |
| 0001A | <1% | 114 | $556.94 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 44 | $546.18 |
| 84702 | <1% | 97 | $522.29 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,102 | $488.23 |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 27 | $472.29 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 307 | $412.13 |
| J2704 | Injection, propofol, 10 mg | <1% | 39 | $377.89 |
| 90715 | <1% | 14 | $304.64 | |
| 86901 | <1% | 158 | $303.85 | |
| 82077 | <1% | 128 | $287.61 | |
| 73130 | <1% | 16 | $271.88 | |
| 83605 | <1% | 152 | $270.43 | |
| 85379 | <1% | 74 | $250.74 | |
| 87088 | <1% | 154 | $223.59 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 268 | $207.44 |
| 81025 | <1% | 950 | $201.44 | |
| 87186 | <1% | 51 | $167.04 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 68 | $156.90 |
| 81003 | <1% | 125 | $129.42 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $112.85 |
| 87481 | <1% | 18 | $83.79 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $83.10 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 16 | $76.60 |
| 83615 | <1% | 14 | $49.99 | |
| 84550 | <1% | 14 | $43.38 | |
| 87040 | <1% | 13 | $28.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 49 | $23.72 |
| 80320 | <1% | 23 | $23.52 | |
| 82550 | <1% | 19 | $21.57 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 155 | $18.37 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 58 | $11.31 |
| 87077 | <1% | 12 | $7.10 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 27 | $3.35 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 15 | $2.72 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 151 | $0.00 |
| 94664 | 0% | 16 | $0.00 | |
| 87511 | 0% | 16 | $0.00 | |
| 96376 | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialELDERS, ROBERT (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.